在接受PMX-DHP治疗的COVID-19患者的炎症和凝血标志物变化
Akinari Tsukada1, Daisuke Katagiri2, Shinyu Izumi1
1Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, JPN.
Cureus
|March 14, 2025
概括
聚氨酸B不动化的纤维柱 (PMX-DHP) 治疗改善了COVID-19患者的氧化. 这种血液输血疗法还调节了炎症性细胞因子,凝血因子和微生物群衍生的.
科学领域:
- 关键护理医学 关键护理医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
背景情况:
- COVID-19可能会导致严重的呼吸困扰和全身炎症.
- 聚氨酸B不动化的纤维柱直接输血 (PMX-DHP) 用于去除内毒素和炎症介质.
- 需要进一步调查PMX-DHP对COVID-19患者特定生物标志物的影响.
研究的目的:
- 评估PMX-DHP在改善COVID-19患者呼吸功能方面的疗效.
- 评估PMX-DHP治疗后细胞因子水平,凝血因子和微生物群衍生的变化.
- 分析治疗期间这些生物标志物变化的时间进程.
主要方法:
- 一个多中心,前性,单臂干预研究.
- 招募了21名需要氧气的COVID-19患者.
- 在PMX-DHP治疗的第1,4和15天对PaO2/FiO2比率和各种生物标志物的分析.
主要成果:
- 在第4天和第15天观察到PaO2/FiO2比率的显著改善.
- 观察到炎症性细胞因子IL-8和IL-10的水平降低.
- 观察到凝血标志物的调节,包括血栓激素的增加和组织等离子素激活剂-等离子素激活剂-1的减少.
- 在4日和15日显著降低了微生物群衍生的素水平.
结论:
- 在COVID-19患者中,PMX-DHP治疗导致呼吸功能得到改善.
- 该疗法有效调节了关键的炎症和凝血生物标志物.
- PMX-DHP对研究的生物标志物产生了积极影响,这表明它在管理严重的COVID-19中具有潜在的治疗作用.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
40
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
40
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
76
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
76